WE BRING OUR PHARMA EXPERTISE TO THE CANNABIS MARKET
PurCann Pharma is proud to announce its participation in a study evaluating the potential efficacy of cannabinoids to relieve the symptoms of multiple sclerosis.
This year, the conference will once again bring together several players in the cannabis industry from Canada and even Europe, from different fields such as science, R&D, politics and the medical field.
Important news for PurCann Pharma and Groupe SiliCycle : PurCann Pharma has completed the acquisition of Neptune Wellness Solutions' cannabis division!
a multidisciplinary team of recognized experts
PurCann Pharma benefits from Groupe SiliCycle’s 25 years experience with extracting and purifying active ingredients from natural biomass.
Contact us to get more information or discuss your project!